AtriCure ATRC Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$100K-112% | -$37K+79.4% | $42K+108% | $9K-96.5% | $812K+2,800% | ||
| $8.96M+245% | $108K+102% | —— | -$267K+96.6% | -$6.19M+22.7% | ||
| $0.18+238% | $0.00+100% | —— | -$0.01+94.1% | -$0.13+23.5% | ||
| $14.24M+1,495% | $5.8M+767% | —— | $5.38M+317% | -$1.02M+61.3% | ||
| $9.67M+256% | $526K+109% | —— | $208K+103% | -$6.19M+13.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is AtriCure's revenue?
- AtriCure (ATRC) generated $569.6M in revenue over the trailing twelve months, up 13.9% year over year.
- Is AtriCure profitable?
- AtriCure reported $2.6M in net income over the trailing twelve months, a -5.6% net margin.
- What are AtriCure's profit margins?
- Gross margin is 76.3% and operating margin is -5.1%, with a -5.6% net margin.
- What is AtriCure's earnings per share?
- AtriCure's diluted EPS over the trailing twelve months is $0.04.
- Where does AtriCure's income statement data come from?
- Every line is extracted from AtriCure's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
